Rare Tumors
Scope & Guideline
Transforming the landscape of rare tumor research.
Introduction
Aims and Scopes
- Clinical Characteristics and Outcomes:
The journal emphasizes the clinical presentation, characteristics, and treatment outcomes of rare tumors, providing insights that can guide clinical practice and improve patient management. - Case Reports and Literature Reviews:
A significant portion of the journal is dedicated to detailed case reports and literature reviews, which highlight unique and rare tumor presentations, diagnostic challenges, and therapeutic approaches. - Multidisciplinary Approaches to Rare Tumors:
The journal encourages discussions on multidisciplinary treatment strategies involving surgery, chemotherapy, radiation, and emerging therapies for managing rare tumors. - Emerging Therapies and Innovations:
It explores novel therapeutic options and advancements in the management of rare tumors, including the use of immunotherapies and targeted therapies. - Global Perspectives on Rare Tumors:
The journal features studies from various geographical locations, allowing for a broader understanding of rare tumors in diverse populations and healthcare settings.
Trending and Emerging
- Innovative Immunotherapies:
There is a growing emphasis on the exploration of immunotherapy as a treatment modality for various rare tumors, reflecting a broader trend in oncology towards personalized and targeted treatment options. - Psychosocial and Quality of Life Studies:
Recent papers are increasingly addressing the psychosocial aspects and quality of life of patients with rare tumors, highlighting the importance of holistic patient care beyond just clinical outcomes. - Multidisciplinary Treatment Approaches:
The trend towards collaborative, multidisciplinary treatment strategies is evident, with more studies focusing on how combined efforts from different specialties can enhance patient outcomes for rare tumors. - Genetic and Molecular Characterization:
There is an emerging focus on the genetic and molecular profiling of rare tumors, contributing to a better understanding of tumor behavior and potential targeted therapies. - Global Health Perspectives:
An increase in studies that consider global health perspectives on rare tumors, including case reports from diverse geographical regions, is evident, promoting a more inclusive understanding of these malignancies.
Declining or Waning
- General Tumor Biology Studies:
There has been a noticeable decrease in publications focusing solely on the basic biology of rare tumors, as the journal shifts towards more clinically relevant case studies and treatment outcomes. - Traditional Chemotherapy Protocols:
The frequency of papers discussing traditional chemotherapy protocols for rare tumors is declining, possibly due to the rise of targeted therapies and immunotherapies that are gaining prominence in treatment discussions. - Epidemiological Studies of Rare Tumors:
Fewer epidemiological studies are being published, suggesting a waning interest in the statistical analysis of rare tumor incidence and prevalence, which may have been overshadowed by more pressing clinical insights and therapeutic innovations.
Similar Journals
SAGE Open Medical Case Reports
Fostering Collaboration Through Shared Medical KnowledgeSAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.
Case Reports in Gastrointestinal Medicine
Transforming gastrointestinal medicine through shared experiences.Case Reports in Gastrointestinal Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of significant findings in the field of gastrointestinal medicine. Established in 2011, this journal champions the accessibility of scholarly work, allowing researchers, professionals, and students to explore vital case studies that enhance clinical understanding and patient care across various gastrointestinal conditions. With an emphasis on innovative practices and advances in treatment, the journal serves as an invaluable resource for those committed to furthering their knowledge and improving outcomes in gastrointestinal health. By promoting the robust sharing of case reports and clinical insights, Case Reports in Gastrointestinal Medicine not only contributes to the academic community but also supports practitioners in their quest for evidence-based practice.
Ocular Oncology and Pathology
Unveiling the Mysteries of Ocular NeoplasmsOcular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.
Endocrinology Diabetes and Metabolism Case Reports
Unlocking the Secrets of Diabetes ManagementEndocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.
Acta Oto-Laryngologica Case Reports
Sharing Transformative Research for Global Health ImpactActa Oto-Laryngologica Case Reports, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to the dissemination of high-quality case reports in the field of otolaryngology. Since its inception in 2016, this journal has been a vital platform for researchers and clinicians to share unique clinical insights and advancements related to ear, nose, and throat disorders. With an ISSN of 2377-2484, it provides unparalleled access to the latest findings, facilitating collaboration and innovation among professionals in otolaryngology. The journal's commitment to open-access publishing ensures that critical research is freely available to a global audience, enhancing the visibility and impact of its contributors' work. Researchers, practitioners, and students in the medical field will find valuable resources and case studies that not only contribute to professional development but also address current challenges in patient care.
Case Reports in Oncology
Exploring Innovative Treatment StrategiesCase Reports in Oncology is a peer-reviewed journal published by KARGER, dedicated to the dissemination of high-quality case studies and clinical reports in the field of oncology. Since its transition to Open Access in 2008, this Swiss-based journal has aimed to broaden the accessibility of key findings to a global audience of researchers, healthcare professionals, and students. The journal is positioned in the Q3 quartile for oncology, indicating its valuable contribution to the field, while also holding a Scopus rank of 294 out of 404 in Medicine, with a percentile of 27%. However, its open access model ensures that even those outside of traditional academic institutions can engage with critical advancements and novel insights from the oncology community. With a publication span extending from 2010 to 2024, Case Reports in Oncology serves as a crucial platform for sharing unique clinical experiences and innovative treatment strategies, ultimately enriching the practice and study of oncology.
Oxford Medical Case Reports
Advancing clinical knowledge through unique case insights.Oxford Medical Case Reports is a pivotal open-access journal published by Oxford University Press that has been a significant contributor to the field of medical literature since its inception in 2014. With an ISSN of 2053-8855, this journal aims to disseminate case reports that enhance the understanding of infectious diseases, microbiology, and parasitology. While currently positioned in the Q4 quartile in these fields, the journal is dedicated to presenting unique clinical insights that not only foster professional development but also support the educational needs of students and emerging researchers. Its open-access model ensures that vital research is accessible to a global audience, facilitating knowledge sharing and collaboration across disciplines. With an ambition to improve its rankings and a vision to expand its impact on medical practice, Oxford Medical Case Reports stands as a valuable resource for healthcare professionals striving to stay informed about the latest case-based advancements in their fields.
Clinical Genitourinary Cancer
Innovating research for a healthier tomorrow.Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.
Leukemia Research Reports
Unlocking the future of leukemia treatment.Leukemia Research Reports, published by Elsevier Advanced Technology, is a prominent open-access journal dedicated to the latest advancements in the field of hematology and oncology. Since its launch in 2012, this journal has been a vital resource for researchers, healthcare professionals, and students aiming to disseminate and access high-quality research articles focused on various aspects of leukemia and related blood disorders. With an impact factor indicative of its significance in the field, Leukemia Research Reports currently holds a Q3 quartile ranking in both Hematology and Oncology, and is included in key databases such as Scopus. The journal not only embraces a commitment to open access, ensuring that research is freely available, but also actively promotes collaborations that strive to enhance our understanding and treatment of leukemia. Based in the United Kingdom, this journal continues to play a crucial role in fostering innovation and knowledge sharing within the medical community.
International Cancer Conference Journal
Innovating Oncology: Insights for a Healthier TomorrowInternational Cancer Conference Journal, published by Springer International Publishing AG, serves as a pivotal platform for the dissemination of cutting-edge research in the field of oncology. With a commitment to advancing the understanding, prevention, and treatment of cancer, this journal offers a forum for the presentation of innovative studies, clinical trials, and comprehensive reviews that cater to the needs of researchers, healthcare professionals, and students alike. Although currently not open access, the journal is dedicated to fostering collaboration and knowledge sharing within the cancer research community. The ISSN for this journal is 2192-3183, ensuring its listing within prominent academic databases for enhanced visibility. Hailing from Switzerland, the journal aspires to impact the global dialogue on cancer through rigorous peer-reviewed articles and special conference proceedings, making it an essential resource for those dedicated to the fight against cancer.